by James | Health & Medical
Having spent over a decade in pharmaceutical research and development, I’ve witnessed the remarkable transformation of hepatitis C from a largely untreatable condition to one with cure rates exceeding 95%. The current landscape of hepatitis C clinical research...
by James | Financial Services
After spending a decade analyzing drug development investments and regulatory risk factors, I’ve developed a systematic approach to evaluating alternative investments that most financial advisors never consider. Gold IRAs operate within a complex regulatory...